Cargando…

Defibrotide Therapy for SARS-CoV-2 ARDS

BACKGROUND: SARS-CoV-2-related ARDS is associated with endothelial dysfunction and profound dysregulation of the thrombotic-fibrinolytic pathway. Defibrotide is a polyanionic compound with fibrinolytic, antithrombotic, and antiinflammatory properties. RESEARCH QUESTION: What is the safety and tolera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frame, David, Scappaticci, Gianni B., Braun, Thomas M., Maliarik, Mary, Sisson, Thomas H., Pipe, Steven W., Lawrence, Daniel A., Richardson, Paul G., Holinstat, Michael, Hyzy, Robert C., Kaul, Daniel R., Gregg, Kevin S., Lama, Vibha N., Yanik, Gregory A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians 2022
Materias:	Critical Care: Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993696/ https://www.ncbi.nlm.nih.gov/pubmed/35413279 http://dx.doi.org/10.1016/j.chest.2022.03.046

Ejemplares similares

Defibrotide Therapy for Sars CoV2 Acute Respiratory Distress Syndrome
por: Yanik, Gregory A, et al.
Publicado: (2021)

SHAKEN, NOT STIRRED: HIGH FREQUENCY PERCUSSIVE VENTILATION AS A SALVAGE THERAPY IN SEVERE ARDS DUE TO COVID-19
por: KHURANA, NEHARIKA, et al.
Publicado: (2021)

PROLONGED, PROFOUND UNTREATED HYPOXIA IN COVID-19 ARDS WITH REFUSAL OF TREATMENT
por: THOMAS, KALEB, et al.
Publicado: (2021)

ARDS following oesophagectomy: a comparison of two trials
por: Howells, Phillip A, et al.
Publicado: (2017)

Tidal changes on CT and progression of ARDS
por: Cereda, Maurizio, et al.
Publicado: (2017)

MANAGEMENT OF PNEUMOTHORAX AND PNEUMOMEDIASTINUM IN COVID-19 PATIENTS WITH ARDS
por: BAKER, COLBY M., et al.
Publicado: (2022)

Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS)
por: Dancer, Rachel C A, et al.
Publicado: (2015)

EXTRA-CORPOREAL CARBON DIOXIDE REMOVAL IN COVID-19 ARDS
por: Boparai, Sukhmani, et al.
Publicado: (2020)

PROVIDER EXPERIENCE WITH PRONE POSITIONING FOR ARDS DURING COVID-19
por: HOCHBERG, CHAD, et al.
Publicado: (2021)

CHANGES IN ARDS MANAGEMENT AS A RESULT OF THE COVID-19 PANDEMIC
por: MACHURICK, MAXWELL, et al.
Publicado: (2021)

COVID-19 AND A HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-LIKE SYNDROME IN THE ABSENCE OF ARDS
por: White, Kyle, et al.
Publicado: (2020)

ENDOTRACHEAL INTUBATION TIMING AND OUTCOME IN ARDS DUE TO COVID-19 INFECTION
por: PEREZ GUTIERREZ, VICTOR, et al.
Publicado: (2021)

ELEVATED D-DIMER PREDICTS DETERIORATION OF ARDS IN PATIENTS WITH COVID-19
por: LOPEZ RUIZ, ARNALDO, et al.
Publicado: (2021)

PNEUMOTHORAX, PNEUMOMEDIASTINUM, AND SUBCUTANEOUS EMPHYSEMA IN COVID-19 ARDS: OUR EXPERIENCE
por: FALSINI, L., et al.
Publicado: (2022)

LUCINACTANT, A SYNTHETIC SURFACTANT FOR TREATMENT OF COVID-19-ASSOCIATED ARDS
por: GUARDIA, CARLOS G, et al.
Publicado: (2022)

The Effect of Alcohol Consumption on the Risk of ARDS: A Systematic Review and Meta-Analysis
por: Simou, Evangelia, et al.
Publicado: (2018)

A CASE OF PRIAPISM IN A MAN ADMITTED TO THE ICU FOR COVID-19 ARDS
por: ANDERSEN, KARL, et al.
Publicado: (2021)

EARLY GAS EXCHANGE PARAMETERS NOT ASSOCIATED WITH SURVIVAL IN COVID-19-ASSOCIATED ARDS PATIENTS REQUIRING PROLONGED VENOVENOUS EXTRACORPOREAL MEMBRANE OXYGENATION
por: DAVIS, ANDREW J., et al.
Publicado: (2022)

COVID-19-RELATED ARDS PHENOTYPES AND PROGRESSION BETWEEN THEM: A CASE REPORT
por: Steff, Rodney, et al.
Publicado: (2020)

USE OF TISSUE PLASMINOGEN ACTIVATOR IN COVID-19 ARDS: A RETROSPECTIVE CASE SERIES
por: NEMEH, CHRISTOPHER, et al.
Publicado: (2021)

HYPONATREMIA SECONDARY TO VASOPRESSIN IN AN ECMO DEPENDENT PATIENT WITH SEVERE ARDS DUE TO COVID-19
por: HAFEEZ, ZEESHAN, et al.
Publicado: (2021)

DOES EXTRACORPOREAL MEMBRANE OXYGENATION SAVE LIVES IN COVID-19-ASSOCIATED SEVERE ARDS
por: VARGHESE, JOBIN, et al.
Publicado: (2021)

PROPOFOL-RELATED INFUSION SYNDROME IN A PATIENT WITH ARDS SECONDARY TO THE NOVEL COVID-19
por: FREEMAN, HOWARD, et al.
Publicado: (2021)

CORRELATION OF C-REACTIVE PROTEIN (CRP) WITH ICU COVID-19 ARDS MORTALITY IN ADULTS
por: CHANDRAN, RAVI T, et al.
Publicado: (2022)

Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study
por: Spadaro, Savino, et al.
Publicado: (2017)

IMPROVED SURVIVAL OUTCOME IN PATIENTS WITH SARS-COV-2 (COVID-19) ARDS WITH TOCILIZUMAB ADMINISTRATION
por: Wadud, Nafisa, et al.
Publicado: (2020)

COMPARISON OF COVID-19 PATIENTS ADMITTED TO THE HOSPITAL WITH ARDS AND THOSE WHO PROGRESS TO IT DURING HOSPITALIZATION
por: IMRAN, MARYAM, et al.
Publicado: (2021)

OUTCOMES OF EXTRACORPOREAL MEMBRANE OXYGENATION IN ARDS DUE TO COVID-19: COMPARISON OF THE FIRST AND THE SECOND WAVE
por: REDDY, ROHIT, et al.
Publicado: (2021)

AIRWAY PRESSURE RELEASE VENTILATION USE IN COVID-19 ARDS: A SINGLE CENTER OBSERVATIONAL STUDY
por: PERINKULAM SATHYANARAYANAN, SWAMINATHAN, et al.
Publicado: (2021)

IMPROVING COMPLIANCE WITH CONTINUOUS ANTERIOR CHEST COMPRESSION IN ARDS CAUSED BY COVID-19: A CASE SERIES
por: PENG, JASON L, et al.
Publicado: (2022)

PRONE POSITIONING IN COVID-19 VS NON-COVID-19 ARDS IN THE EARLY COVID-19 PANDEMIC
por: LIEBERMAN, ALLYSON E, et al.
Publicado: (2022)

Mesenchymal stromal cells-derived extracellular vesicles reprogramme macrophages in ARDS models through the miR-181a-5p-PTEN-pSTAT5-SOCS1 axis
por: Su, Yue, et al.
Publicado: (2023)

Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model
por: Cardenes, Nayra, et al.
Publicado: (2019)

Clinical characteristics of patients with a risk of pulmonary artery hypertension secondary to ARDS in a high-altitude area
por: Zhu, Peng, et al.
Publicado: (2023)

Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience
por: Mahida, Rahul Y, et al.
Publicado: (2020)

OLD MEDICINE FOR NEW PROBLEMS: POTENTIAL ROLE OF A NOVEL TREATMENT USING NEBULIZED HEPARIN IN COVID-19 ARDS
por: DOUEN, AARON, et al.
Publicado: (2021)

NEUROMUSCULAR BLOCKING AGENT BUNDLES IN THE MEDICAL ICU TO PREVENT PROLONGED USE OF PARALYTICS IN PATIENTS WITH COVID-19-RELATED ARDS
por: PINCHOVER, ZACHARY S, et al.
Publicado: (2022)

CIRCULATING DAMAGE-ASSOCIATED MOLECULAR PATTERNS (DAMPS) AS PROGNOSTIC MARKERS OF DISEASE SEVERITY IN PATIENTS WITH COVID-19 ARDS IN THE ICU
por: ALGHANIM, FAHID, et al.
Publicado: (2022)

RADIOGRAPHIC AND CLINICAL CORRELATIONS IN SURVIVORS WITH POST-ARDS RELATED COVID-19: WHAT ARE RISK FACTORS FOR RESIDUAL PULMONARY ABNORMALITIES?
por: SADIGOV, ALIZAMIN SI
Publicado: (2022)

IMPACT OF VENTILATOR MODEL ON MORTALITY: A RETROSPECTIVE CROSS-SECTIONAL STUDY IN 147 MECHANICALLY VENTILATED PATIENTS WITH COVID-19 ARDS
por: Castaneda, Christian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8afld39b5ng5nmshtsid9lirbk